Tesla
TSLA
Netflix
NFLX
Adobe
ADBE
4
Alphabet-A
GOOGL
5
Alphabet-C
GOOG
US Stock MarketDetailed Quotes
OGN Organon & Co
- 14.720
- -0.610-3.98%
Close Mar 25 16:00 ET
- 14.760
- +0.040+0.27%
Post 18:36 ET
3.80BMarket Cap4.42P/E (TTM)
15.361High14.675Low3.42MVolume15.330Open15.330Pre Close50.95MTurnover1.33%Turnover Ratio4.42P/E (Static)257.95MShares22.28752wk High8.04P/B3.78BFloat Cap13.61952wk Low1.12Dividend TTM256.99MShs Float33.350Historical High7.61%Div YieldTTM4.48%Amplitude10.015Historical Low14.909Avg Price1Lot Size
About Organon & Co Company
Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.
Company Profile
SymbolOGN
Company NameOrganon & Co
Listing DateMay 14, 2021
Founded2020
CEOMr. Kevin Ali
MarketNYSE
Employees10000
Fiscal Year Ends12-31
Address30 Hudson Street,33rd floor
CityJersey City
ProvinceNew Jersey
CountryUnited States of America
Zip Code07302
Phone1-551-430-6900
Websitehttp://www.organon.com
Company Executives
- Name
- Position
- Salary
- Kevin Ali
- Chief Executive Officer and Director
- 14.83M
- Dr. Juan Camilo Arjona Ferreira, M.D.
- Executive Vice President, Head of Research and Development and Chief Medical Officer
- --
- Matthew M. Walsh
- Executive Vice President, Chief Financial Officer and Principal Accounting Officer
- 5.21M
- Rachel A. Stahler
- Executive Vice President and Chief Information Officer
- --
- Aaron Falcione
- Executive Vice President and Chief Human Resources Officer
- --
- Kathryn DiMarco
- Senior Vice President and Corporate Controller
- --
- Kirke Weaver
- Executive Vice President, General Counsel and Corporate Secretary
- 3.19M
- Joseph T. Morrissey, Jr
- Executive Vice President and Head of Manufacturing and Supply
- 3.74M
- Vittorio Nisita
- Executive Vice President and Head of Global Business Services
- --
- Carrie S. Cox
- Chairman of the Board
- 450.00K
- Rochelle B. Lazarus
- Independent Director
- 320.00K
- Deborah R. Leone
- Independent Director
- 330.00K
- Dr. Phillip Ozuah, M.D.,PhD
- Independent Director
- 320.00K
- Cynthia M. Patton
- Independent Director
- 330.00K
- Robert A. Essner
- Independent Director
- 335.00K
- Dr. Helene D. Gayle, M.D.
- Independent Director
- 320.00K
- Dr. Alan Ezekowitz, D.Phil.,MB.Ch.B.
- Independent Director
- 330.00K
- Shalini Sharp
- Independent Director
- 345.00K
- Grace Puma Whiteford
- Independent Director
- 320.00K
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call